Genecast (臻和科技)

With next-generation sequencing technology and bioinformatics as the core, the Genecast is engaged in the precise diagnosis and attendant diagnosis of noninvasive-based oncology and is committed to becoming a leader in improving the quality of life of cancer patients. At present, Genecast has established an optimized platform for DNA extraction and quantitative detection technology, with the first China-based detection of multiple DNA-based solid tumors (lung cancer, colorectal cancer, liver cancer, esophageal cancer, endometrial cancer, ovarian cancer , Cervical cancer) with the diagnosis, prognosis, medication guidance technology platform.

75.4logo
logo
logo
logo
logo
logo
75.4
logo
NaN
logo
NaN
logo
NaN
logo
NaN
Links
logologo
Valuation
logo
$
Valuation
Funding
logo
$
$ 149.37 M
$ 242.93 M
Funding
$ 149.37 M
$ 242.93 M
Statistics
logo
NA
Action

With next-generation sequencing technology and bioinformatics as the core, the Genecast is engaged in the precise diagnosis and attendant diagnosis of noninvasive-based oncology and is committed to becoming a leader in improving the quality of life of cancer patients. At present, Genecast has established an optimized platform for DNA extraction and quantitative detection technology, with the first China-based detection of multiple DNA-based solid tumors (lung cancer, colorectal cancer, liver cancer, esophageal cancer, endometrial cancer, ovarian cancer , Cervical cancer) with the diagnosis, prognosis, medication guidance technology platform.

0and0